Jennifer Riley, Chief Officer of Avalo Therapeutics AVTX, has filed 5 transactions, none an open-market purchase or sale. The latest trade was on 06/10.

Jennifer Riley

Chief Strategy Officer

Company: Avalo Therapeutics AVTX
First filing: 25/01/03

Trades: 5 trades
Buys / sales: 0 / 0
12-month net buying: No record
Last trade: 06/10

Trading activity

Transactions

No filed transactions.